MuSigmas provides statistical planning support for early- and late-phase clinical trials and observational studies.
The company works across therapeutic areas, with extensive experience in oncology, cardiovascular disease, central nervous system conditions, rare diseases, vaccine trials and medical devices.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company specializes in adaptive designs, including Bayesian designs, and applies machine learning to biomarker discovery and diagnostic device development.
Source: LinkedIn company description · Retrieved October 13, 2026
The company provides Data Monitoring Committee-related services and support for regulatory defence of clinical trial designs and protocols.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.Snapshot: September 28, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 30, 2026, September 4, 2026, September 10, 2026, September 12, 2026, September 14, 2026, September 15, 2026, September 18, 2026, September 20, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 29, 2026, September 30, 2026, October 7, 2026, October 8, 2026, October 9, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.